Observations placeholder
Tarceva
Identifier
015720
Type of Spiritual Experience
Background
A description of the experience
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
On Dec, 21, 2016 19,014 people reported to have side effects when taking Tarceva.
Among them, 10,373 people (54.55%) have Death
Time on Tarceva when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 45.28% | 39.62% | 8.49% | 6.60% | 0.00% | 0.00% | 0.00% |
On Dec, 28, 2016 19,014 people reported to have side effects when taking Tarceva.
Among them, 44 people (0.23%) have Hallucination
Time on Tarceva when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 40.00% | 40.00% | 0.00% | 20.00% | 0.00% | 0.00% | 0.00% |